Investigation of frequency distribution of human platelet antigen -1to -10 in Luoyang
-
摘要: 目的:研究洛阳地区献血员人类血小板抗原(HPA)1~10基因多态性,为患者提供HPA相配合的血小板。方法:随机收集250例无偿献血员样本,应用聚合酶链式反应-序列特异引物(PCR-SSP)技术检测HPA-1~10基因型及等位基因频率。结果:HPA-1aa、-1ab所占百分比分别为98.80%和1.20%,HPA-2aa、-2ab所占百分比分别为90.80%和9.20%, HPA-4aa、-4ab所占百分比分别为98.00%和2.00%,HPA-5aa、-5ab所占百分比分别为96.40%和3.60%,HPA-aa、-ab、-bb三种基因型在HPA-3和HPA-6中的比例分别为29.20%、46.00%、24.80%和91.60%、6.80%、1.60%,在HPA-7、-8、-9、-10中仅检测到HPA-aa纯合子。结论:洛阳地区HPA-1~HPA-10基因分布与文献报道相似,HPA-3特异性抗体是引起本地区HPA同种免疫性疾病的首要原因。Abstract: Objective: To study the gene polymorphism of human platelet antigen(HPA) -1 to 10,in order to provide patients with the HPA compatible platelets.Method: A total of 250 samples were collected from the blood donors randomly, and the genotypes and allele frequencies of HPA-1 to 10 were detected by polymerase chain reaction sequence specific primers (PCR-SSP). Result: The percentages of HPA-1aa and-1ab were 98.80% and 1.20% respectively. The percentages of HPA-2aa and-2ab were 90.80% and 9.20% respectively. The percentages of HPA-4aa and-4ab were 98.00% and 2.00% respectively. The percentages of HPA-5aa and-5ab were 96.40% and 3.60% respectively. The proportions of HPA-aa,-ab and-bb in HPA-3 and HPA-6 were 29.20%,46.00%,24.80% and 91.60%,6.80%,1.60% respectively. The HPA-aa homozygous only was detected out in HPA-7,-8,-9,-10.Conclusion: The gene distributions of HPA-1 to HPA-10 was similar to those reported in the literature. The HPA-3 specific antibody was the major cause for HPA autoimmune diseases in Luoyang.
-
Key words:
- human platelet antigen /
- gene /
- blood group /
- PCR-SSP
-
-
[1] 张冬霞.吉林地区汉族人群血小板抗原系统基因分型研究[J].中国输血杂志,2011,24(10):46-47.
[2] 周琼秀,李执如,陈静娴.PCR-SSP在人类血小板抗原1-6、15系统基因分型中的应用[J].中国输血杂志,2009,22(4):43-44.
[3] MCYEY M, CSERTI-GAZDEWICH C M.Platelet transfusion refractoriness responding preferentially to single donor aphaeresis platelet compatible for both ABO and HLA[J].Transfus Med.2010,20:346-353.
[4] XIA W J, YE X, TIAN L W,et al.Establishment of platelet donor registry improves the treatment of platelet transfusion refractoriness in Guangzhou region of China[J]. Transfus Med, 2010, 20:269-274.
[5] FENG M L, LIU D Z, SHEN W, et al. Establishment of an HPA-1-to -16-typed platelet donor registry in China[J]. Transfus Med,2006,16:369-374.
[6] COLLINS C L, SCOTT J P, PANEPINTO J A, et al. Severe thrombocytopenia in a child secondary to passive platelet antibody transfer from a plasma transfusion[J].J Pediatr Hematol Oncol,2013,35:226-228.
[7] SHEHATA N, DENOMME G A, HANNACH B, et al. Mass-scale high-throughput multiplex polymerase chain reaction for human platelet antigen single-nucleotide polymorphisms screening of apheresis platelet donors[J]. Transfusion,2011,51:2028-2033.
[8] BHATTI F A, UDDIN M, AHMED A, et al.Human platelet antigen polymorphisms (HPA-1, -2, -3, -4, -5 and -15) in major ethnic groups of Pakistan[J]. Transfus Med,2010,20:78-87.
-
计量
- 文章访问数: 144
- PDF下载数: 88
- 施引文献: 0